SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+0.25%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$520M
AUM Growth
+$520M
(+0.68%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
129
New
9
Increased
50
Reduced
34
Closed
11
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$9.6M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$5.08M |
| 3 |
TSVT
2seventy bio
TSVT
|
$4.86M |
| 4 |
Treace Medical Concepts
TMCI
|
$4.7M |
| 5 |
Vera Therapeutics
VERA
|
$4.66M |
Top Sells
| 1 |
Exelixis
EXEL
|
$8.88M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$6.05M |
| 3 |
iRhythm Technologies
IRTC
|
$4.59M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.22M |
| 5 |
Arrowhead Research
ARWR
|
$3.87M |
Sector Composition
| 1 | Healthcare | 95.06% |
| 2 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Regeneron Pharmaceuticals
REGN
$59.8B
| $2.29M | 0.44% |
2,790
+80
| +3% | +$65.7K |
|
|
RETA
77
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.27M | 0.44% |
+25,000
| New | +$2.27M |
|
78
Vaxcyte
PCVX
$4.17B
| $2.25M | 0.43% |
60,000
| – | – |
|
79
Gilead Sciences
GILD
$140B
| $2.13M | 0.41% |
25,700
-350
| -1% | -$29K |
|
80
Vertex Pharmaceuticals
VRTX
$102B
| $2.09M | 0.4% |
6,619
-400
| -6% | -$126K |
|
81
Altimmune
ALT
$325M
| $2.02M | 0.39% |
479,100
+136,600
| +40% | +$576K |
|
82
Beam Therapeutics
BEAM
$1.9B
| $1.94M | 0.37% |
63,500
| – | – |
|
83
Humana
HUM
$37.5B
| $1.74M | 0.33% |
3,575
| – | – |
|
84
Generation Bio
GBIO
$40.3M
| $1.66M | 0.32% |
385,070
+111,283
| +41% | +$479K |
|
85
BioAtla
BCAB
$28.7M
| $1.46M | 0.28% |
543,009
+404,715
| +293% | +$1.08M |
|
86
Mersana Therapeutics
MRSN
$34.8M
| $1.41M | 0.27% |
+343,079
| New | +$1.41M |
|
87
AstraZeneca
AZN
$255B
| $1.39M | 0.27% |
20,010
| – | – |
|
88
4D Molecular Therapeutics
FDMT
$302M
| $1.38M | 0.26% |
80,029
+26,193
| +49% | +$450K |
|
|
PNT
89
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.33M | 0.26% |
182,668
-2,610
| -1% | -$19K |
|
90
Atea Pharmaceuticals
AVIR
$275M
| $1.28M | 0.25% |
380,850
+99,447
| +35% | +$333K |
|
91
Annexon
ANNX
$225M
| $1.26M | 0.24% |
+326,806
| New | +$1.26M |
|
|
ITOS
92
DELISTED
iTeos Therapeutics
ITOS
| $1.2M | 0.23% |
88,373
+30,611
| +53% | +$417K |
|
93
PMV Pharmaceuticals
PMVP
$82.1M
| $1.19M | 0.23% |
+250,469
| New | +$1.19M |
|
|
ONC
94
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $1.19M | 0.23% |
5,510
-470
| -8% | -$101K |
|
|
EXAI
95
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $1.11M | 0.21% |
210,303
-54,795
| -21% | -$290K |
|
96
Scholar Rock
SRRK
$3.3B
| $1.08M | 0.21% |
134,569
-16,638
| -11% | -$133K |
|
97
Illumina
ILMN
$15.2B
| $1.05M | 0.2% |
4,520
-100
| -2% | -$23.1K |
|
|
EFTR
98
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $840K | 0.16% |
2,382,644
| – | – |
|
|
HZNP
99
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $644K | 0.12% |
5,900
-900
| -13% | -$98.2K |
|
100
Sanofi
SNY
$122B
| $484K | 0.09% |
8,900
| – | – |
|